Cellulitis Completed Phase 3 Trials for Olanzapine (DB00334)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs